Jim Cramer Says You Should ‘Stay Long’ Eli Lilly (LLY) Because of These Reasons
We recently published a list of Jim Cramer Was Talking About These 10 Stocks Amid Trump’s Trade Wars. In this article, we are ...
Why April Could Be a Huge Month for Eli Lilly Stock
Eli Lilly (NYSE: LLY) is the most valuable healthcare company in the world, worth more than $700 billion. Over the past 12 ...
Eli Lilly (NYSE:LLY) Unveils Positive Phase 2 Results For Heart Disease Therapy Amid 5% Share Dip
Eli Lilly (NYSE:LLY) experienced a 6% increase in price over the last quarter, coinciding with several major developments.
Where Will Eli Lilly Be in 1 Year?
Lately, however, Eli Lilly's stock has cooled. Shares have been essentially flat since July 2024. The market for GLP-1 ...
‘Don’t Fall for the Hype,’ Says Top Analyst about HIMS’ Decision to Sell Zepbound
Shares of Hims & Hers Health (HIMS) rallied on Tuesday after the telehealth company said it would begin selling branded versions of Eli ...
Check Out What Whales Are Doing With LLY
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include ...
Explore more
Eli Lilly’s (LLY) Alzheimer’s Drug Is Rejected in Europe Over Safety Fears
A European health committee has rejected Eli Lilly’s Alzheimer’s drug, Kisunla, because of safety concerns about possible ...
Altria vs. Eli Lilly: What's the Better Stock for Dividend Investors?
Altria has an impressive streak of raising its dividend for 55 consecutive years. Eli Lilly's current streak only goes back ...
Nasdaq18d
NVO vs. LLY: Which Stock Is the Better Value Option?
LLY currently has a PEG ratio of 1.31. Another notable valuation metric for NVO is its P/B ratio of 16.64. The P/B ratio pits a stock's market value against its book value, which is defined as ...